Design Therapeutics Announces Four-Week IV Data from the RESTORE-FA Trial of DT-216P2 Demonstrating Clinical Improvements and Comprehensive Biomarker Activity in FA
Industry News
Blog|May 18 2026
Meet The Community: Shay
Community
News|May 15 2026
Press release and community statement: Lexeo Therapeutics Reports First Quarter 2026 Financial Results and Operational Highlights
Industry News
Blog|May 11 2026
Meet The Community: Christina Laurin
Community
Blog|May 5 2026
Meet The Community: Amelia and Laurel
Community
News|May 1 2026
May is FA Awareness Month: Help raise awareness and move research forward!
News|Apr 27 2026
April 2026 – Advocacy Newsletter
Advocacy
Blog|Apr 27 2026
Meet The Community: Frankie Leath
Community
News|Apr 22 2026
Community Statement: Update from Biogen
Industry News
Blog|Apr 20 2026
Good Times, Big Hearts, and Movements Toward a Cure: Recap of rideATAXIA Hometown Lake Charles 2026
Events
News|Apr 17 2026
Job Posting: Director of Finance & Accounting
FARA News
Blog|Apr 13 2026
Meet the Community 2: A Closer Look – Ilva Johannsdóttir Madsen